These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 1659851)

  • 1. Treatment of extensive small cell lung cancer with carboplatin and teniposide.
    Sørensen BT; Nielsen K; Steenholdt S; Schultz H; Jakobsen A
    Eur J Cancer; 1991; 27(9):1109-12. PubMed ID: 1659851
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Teniposide (VM-26) and carboplatin as initial therapy for small cell lung cancer.
    Goss GD; Vincent M; Corringham R; Germond C; Sinoff C; Kane G; Rowen J; Corringham S; Dhaliwal H
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):69-74. PubMed ID: 1329228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combination chemotherapy with teniposide (VM26) and carboplatin in small cell lung cancer.
    Goss GD; Vincent M; Germond C; Corringham S; Rowen J; Dhaliwal H; Corringham R
    Am J Clin Oncol; 1993 Aug; 16(4):295-300. PubMed ID: 8392286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carboplatin and etoposide in extensive small cell lung cancer.
    Viren M; Liippo K; Ojala A; Helle L; Hinkka S; Huovinen R; Jakobsson M; Järvinen M; Paloheimo S; Salmi R
    Acta Oncol; 1994; 33(8):921-4. PubMed ID: 7818926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chemotherapy of small-cell lung cancer by a combination of teniposide, ifosfamide and carboplatin].
    Moro D; Orfeuvre H; Nagy-Mignotte H; Mousseau M; Blanc-Jouvan F; Schaerer R; Brambilla C
    Bull Cancer; 1994 Jan; 81(1):38-42. PubMed ID: 7949582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel, carboplatin, and extended-schedule etoposide in the treatment of small-cell lung cancer: comparison of sequential phase II trials using different dose-intensities.
    Hainsworth JD; Gray JR; Stroup SL; Kalman LA; Patten JE; Hopkins LG; Thomas M; Greco FA
    J Clin Oncol; 1997 Dec; 15(12):3464-70. PubMed ID: 9396399
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superiority of high-dose platinum (cisplatin and carboplatin) compared to carboplatin alone in combination chemotherapy for small-cell lung carcinoma: a prospective randomised trial of 280 consecutive patients.
    Hirsch FR; Osterlind K; Jeppesen N; Dombernowsky P; Ingeberg S; Sorensen PG; Kristensen C; Hansen HH
    Ann Oncol; 2001 May; 12(5):647-53. PubMed ID: 11432623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized, controlled phase III study of cyclophosphamide, doxorubicin, and vincristine with etoposide (CAV-E) or teniposide (CAV-T), followed by recombinant interferon-alpha maintenance therapy or observation, in small cell lung carcinoma patients with complete responses.
    Tummarello D; Mari D; Graziano F; Isidori P; Cetto G; Pasini F; Santo A; Cellerino R
    Cancer; 1997 Dec; 80(12):2222-9. PubMed ID: 9404698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is carboplatin and oral etoposide an effective and feasible regimen in patients with small cell lung cancer?
    Pfeiffer P; Sørensen P; Rose C
    Eur J Cancer; 1995; 31A(1):64-9. PubMed ID: 7695981
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of dose escalation of teniposide (VM-26) plus cisplatin (CDDP) with recombinant human granulocyte colony-stimulating factor (rhG-CSF) in patients with advanced small cell lung cancer.
    Eguchi K; Etou H; Miyachi S; Morinari H; Nakada K; Noda K; Ohkuni Y; Watanabe K; Yamada Y; Ohe Y
    Eur J Cancer; 1994; 30A(2):188-94. PubMed ID: 7512356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of paclitaxel, carboplatin, and topotecan with G-CSF support in previously untreated patients with extensive stage small cell lung cancer: Southwest Oncology Group 9914.
    Hesketh PJ; McCoy J; Dunphy FR; Bearden JD; Weiss GR; Giguere JK; Atkins JN; Dakhil SR; Kelly K; Crowley JJ; Gandara DR
    J Thorac Oncol; 2006 Nov; 1(9):991-5. PubMed ID: 17409984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of brain metastases of small cell lung cancer with teniposide.
    Postmus PE; Smit EF; Berendsen HH; Sleijfer DT; Haaxma-Reiche H
    Semin Oncol; 1992 Apr; 19(2 Suppl 6):89-94. PubMed ID: 1329230
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A phase I study of ifosfamide/carboplatin/etoposide/paclitaxel in advanced lung cancer.
    Strauss GM; Lynch TJ; Elias AD; Jacobs C; Kwiatkowski DJ; Shulman LN; Carey RW; Grossbard ML; Jauss S; Sugarbaker DJ
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):70-4. PubMed ID: 7544029
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Teniposide for brain metastases of small-cell lung cancer: a phase II study. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.
    Postmus PE; Smit EF; Haaxma-Reiche H; van Zandwijk N; Ardizzoni A; Quoix E; Kirkpatrick A; Sahmoud T; Giaccone G
    J Clin Oncol; 1995 Mar; 13(3):660-5. PubMed ID: 7884426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small cell lung cancer (SCLC): a randomized trial of cyclophosphamide, adriamycin, vincristine plus etoposide (CAV-E) or teniposide (CAV-T) as induction treatment, followed in complete responders by alpha-interferon or no treatment, as maintenance therapy.
    Tummarello D; Graziano F; Mari D; Cetto G; Pasini F; Antonio S; Isidori P; Gasparini S
    Anticancer Res; 1994; 14(5B):2221-7. PubMed ID: 7840527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience.
    Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Johnson S; Ozols RF
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):18-29. PubMed ID: 7544025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly carboplatin and VM-26 for elderly patients with small-cell lung cancer.
    Michel G; Leyvraz S; Bauer J; Aapro M; Stahel R; Alberto P
    Ann Oncol; 1994 Apr; 5(4):369-70. PubMed ID: 8075036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical impact of teniposide in the treatment of elderly patients with small-cell lung cancer.
    Cascinu S; Del Ferro E; Ligi M; Graziano F; Catalano G
    Am J Clin Oncol; 1997 Oct; 20(5):477-8. PubMed ID: 9345331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carboplatin and teniposide concurrent with radiotherapy in patients with glioblastoma multiforme: a phase II study.
    Brandes AA; Rigon A; Zampieri P; Ermani M; Carollo C; Altavilla G; Turazzi S; Chierichetti F; Florentino MV
    Cancer; 1998 Jan; 82(2):355-61. PubMed ID: 9445194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitomycin C, vinblastine, and carboplatin regimen in patients with nonsmall cell lung cancer. A phase II trial.
    Paccagnella A; Favaretto A; Oniga F; Festi G; Lauro S; Morabito A; Ossana L; Sartore F; DePoli F; Fiorentino MV
    Cancer; 1996 Oct; 78(8):1701-7. PubMed ID: 8859183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.